Department of Dermatology, Taipei Veterans General Hospital, Taipei, 11221, Taiwan.
Department of Dermatology, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan.
Lasers Surg Med. 2020 Jun;52(5):389-395. doi: 10.1002/lsm.23151. Epub 2019 Sep 4.
There have been few studies regarding the use of a picosecond-domain laser for acne scars in Asians. This prospective study evaluated the efficacy and safety of a high-energy 1,064 nm Nd:YAG picosecond-domain laser for ablation and resurfacing of facial acne scars in Asians.
Subjects were treated with a 1,064 nm picosecond laser (8 mm spot, 0.7-1.0 J/cm , 5 Hz) every 4 weeks for three sessions. Two blinded dermatologists evaluated the pre- and 3-month post-treatment images with a 10-point improvement scale. Subject pain, global improvement, and satisfaction were also assessed. The Facial Acne Scar Quality of Life (FASQoL) questionnaire was used to evaluate the subjects' quality of life.
Twenty subjects aged 18-50 years with Fitzpatrick skin type III-V were enrolled. The median dermatologist-rated improvement score was 3 out of 10. Subjects were satisfied to very satisfied with global improvement. Subjects' quality of life significantly improved with a median FASQoL score of 10 after treatment compared with 21 before treatment (P < 0.001). Adverse effects were limited to erythema, pain, and edema without postinflammatory hyperpigmentation.
The 1,064 nm picosecond-domain laser with ablative resurfacing parameters is safe and effective for the treatment of acne scars in Asians. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.
针对亚洲人痤疮疤痕应用皮秒域激光的研究较少。本前瞻性研究评估了高能 1064nmNd:YAG 皮秒域激光用于亚洲人面部痤疮疤痕消融和重塑的疗效和安全性。
受试者每 4 周接受 1064nm 皮秒激光(8mm 光斑,0.7-1.0J/cm²,5Hz)治疗 3 次。2 名盲法皮肤科医生使用 10 分改善量表评估治疗前和治疗后 3 个月的图像。还评估了受试者的疼痛、整体改善和满意度。使用面部痤疮疤痕生活质量(FASQoL)问卷评估受试者的生活质量。
纳入了 20 名年龄 18-50 岁、皮肤类型为 III-V 型的受试者。中位数皮肤科医生评分改善 3 分(满分 10 分)。受试者对整体改善非常满意。治疗后,受试者的生活质量显著改善,FASQoL 中位数评分从治疗前的 21 分提高至 10 分(P<0.001)。不良反应仅限于红斑、疼痛和水肿,无炎症后色素沉着过度。
具有消融重塑参数的 1064nm 皮秒域激光治疗亚洲人的痤疮疤痕是安全有效的。激光外科医学。© 2019 Wiley Periodicals, Inc.